Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19
NCT ID: NCT04341766
Last Updated: 2020-07-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
106 participants
OBSERVATIONAL
2020-03-31
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The COVID (Coronavirus Disease) epidemic is leading to a large influx of patients in the emergency department with respiratory disorders. The rapid diagnosis of respiratory disorders in infected patients is important for further management.
Chest ultrasound has already demonstrated its value in the diagnosis of pneumonia in the emergency department with superiority over chest X-ray.
However, there is little data on the thoracic ultrasound semiology of viral pneumonia in general and of COVID in particular.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +
NCT04335019
Lung Ultrasound for COVID-19 Initial Triage and Monitoring
NCT04474236
Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study
NCT04338568
CORonavirus (COVID-19) Diagnostic Lung UltraSound Study
NCT04351802
Lung Ultrasound to Diagnose COVID-19
NCT04368338
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
However, there is little data on the thoracic ultrasound semiology of viral pneumonia in general and of COVID in particular.
Peng reported data from 20 patients and compared them to chest CT. The abnormalities are a thickening of the pleuropneumonia line, an interstitial syndrome with B lines, corresponding to frosted glass opacities, confluent B lines (snowstorm appearance) corresponding to interstitial infiltrate, sub-pleural alveolar opacities corresponding to sub-pleural condensations, more frank alveolar images corresponding to alveolar opacities. A multifocal aspect was associated with involvement of more than 2 lobes. However, the frequency of these abnormalities as well as the sensitivity of the echo are not detailed in this article.
Another Italian article describes a clinical case of COVID-19 pneumonia with sub-pleural involvement and irregularity of the pleuro-pulmonary line.
Clinical thoracic ultrasound has a major potential interest during the COVID epidemic: available at the patient's bedside, avoiding the need to move around, feasible for the physician during his visit, easy to clean especially if ultraportable devices are used, fast and not exposing the staff any more than the usual clinical examination.
In order to determine whether this technique is useful in the management of infected patients or patients suspected of COVID-19 infection with respiratory signs, we propose a descriptive prospective study evaluating the ultrasound semiology of COVID-19 pneumonia and the interest of ultrasound in the evolutionary follow-up of these patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient hospitalised with COVID-19 infection
Patients admitted to hospital with proven COVID-19 infection with respiratory signs warranting a chest CT scan
No special intervention
No special intervention : Ultrasound data will be collected
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No special intervention
No special intervention : Ultrasound data will be collected
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Unconscious patient
18 Years
105 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Intercommunal Creteil
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens
Amiens, , France
CH de la Côte Basque
Bayonne, , France
CHU Ambroise Paré
Boulogne-Billancourt, , France
CHU Caen
Caen, , France
CHG de Chambery
Chambéry, , France
Centre Hospitalier Intercommunal de Créteil
Créteil, , France
CHU de Limoges
Limoges, , France
APHM - Hopital Nord
Marseille, , France
CHU de Nancy
Nancy, , France
CHU Nîmes
Nîmes, , France
CHR Orléans
Orléans, , France
CHU Cochin
Paris, , France
CHU Poitiers
Poitiers, , France
CHU Rouen
Rouen, , France
CH Saint-Quentin
Saint-Quentin, , France
CHU Larrey - Toulouse
Toulouse, , France
CHU de Tours
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVID-ECHO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.